SGRY Stock Overview
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Surgery Partners, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$24.04 |
52 Week High | US$45.79 |
52 Week Low | US$22.05 |
Beta | 2.74 |
1 Month Change | -13.56% |
3 Month Change | -21.82% |
1 Year Change | -39.12% |
3 Year Change | -51.39% |
5 Year Change | 121.98% |
Change since IPO | 30.44% |
Recent News & Updates
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Mar 18Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Feb 27Recent updates
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Mar 18Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Feb 27The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)
Dec 19Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)
Oct 26Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?
Sep 17Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?
Aug 26The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising
Jul 21Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit
Jun 15A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
May 26There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital
Apr 14Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet
Mar 24Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jan 24We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt
Sep 26The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence
Aug 15Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M
Aug 02Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders
Jul 02Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Jun 27Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?
Mar 27Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?
Dec 06Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
Oct 04Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet
Aug 05Surgery Partners and UCI Health ink strategic partnership
May 28Shareholder Returns
SGRY | US Healthcare | US Market | |
---|---|---|---|
7D | -2.7% | 6.5% | -3.2% |
1Y | -39.1% | 4.0% | 19.3% |
Return vs Industry: SGRY underperformed the US Healthcare industry which returned 4% over the past year.
Return vs Market: SGRY underperformed the US Market which returned 19.3% over the past year.
Price Volatility
SGRY volatility | |
---|---|
SGRY Average Weekly Movement | 5.9% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SGRY's share price has been volatile over the past 3 months.
Volatility Over Time: SGRY's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 12,000 | J. Evans | www.surgerypartners.com |
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services.
Surgery Partners, Inc. Fundamentals Summary
SGRY fundamental statistics | |
---|---|
Market cap | US$3.03b |
Earnings (TTM) | -US$11.90m |
Revenue (TTM) | US$2.74b |
1.1x
P/S Ratio-254.3x
P/E RatioIs SGRY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SGRY income statement (TTM) | |
---|---|
Revenue | US$2.74b |
Cost of Revenue | US$2.10b |
Gross Profit | US$647.50m |
Other Expenses | US$659.40m |
Earnings | -US$11.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | -0.095 |
Gross Margin | 23.60% |
Net Profit Margin | -0.43% |
Debt/Equity Ratio | 62.4% |
How did SGRY perform over the long term?
See historical performance and comparison